Table 1 Baseline characteristics of the study population
Characteristic | Overall, N = 3364a |
|---|---|
Age, years | 28.00 (19.00–37.00) |
Sex | |
 Female | 1,587 (48.20) |
 Male | 1,777 (51.80) |
Race | |
 Mexican American | 1,036 (10.10) |
 Non-Hispanic Black participants | 886 (12.02) |
 Non-Hispanic White participants | 1,168 (67.51) |
 Other Race | 274 (10.38) |
 BMI, kg/m2 | 25.69 ± 5.70 |
 Waist circumference, cm | 88.07 ± 14.64 |
 SBP, mmHg | 113.24 ± 11.76 |
 DBP, mmHg | 68.56 ± 10.43 |
Physical activity | |
 level 0 | 302 (9.33) |
 level 1 | 529 (16.15) |
 level 2 | 669 (18.82) |
 level 3 | 1,107 (37.22) |
 level 4 | 118 (1.61) |
 level 5 | 208 (4.88) |
 level 6 | 431 (11.98) |
Smoking status | |
 Never smoker | 2,271 (61.92) |
 Former smoker | 442 (14.99) |
 Current smoker | 651 (23.08) |
 Metabolic syndrome | 226 (9.07) |
 CRP, mg/dL | 0.10 (0.04–0.27) |
 Hb, g/dL | 14.59 ± 1.44 |
 Platelet count, 109 /L | 268.26 ± 61.41 |
 LDL, mmol/L | 2.81 ± 0.86 |
 HDL, mmol/L | 1.32 ± 0.36 |
 HbA1c, % | 5.15 ± 0.29 |
 FPG, mmol/L | 5.12 ± 0.45 |
 TG, mmol/L | 1.02 (0.72–1.49) |
 Vo2max, ml/kg/min | 40.89 ± 9.53 |
Levels of CVF | |
 Low level | 924 (20.21) |
 Moderate level | 1,285 (35.48) |
 High level | 1,155 (44.30) |
 Impaired CVF | 2,209 (55.70) |
 TyG index | 8.36 ± 0.52 |
 Standardization of TyG index | 0.03 ± 0.16 |